Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IndoVac Safety and Immunogenicity in Adolescents
NCT05546502Phase 3Completed
- Sponsor
- Bio Farma
- Start
- Oct 2022
- Primary completion
- Dec 2023
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of IndoVac in coronavirus disease 2019 (COVID-19), sponsored by Bio Farma. Started Oct 2022; status: completed.
02
Drugs
IndoVac
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT05546502.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05546502.